400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Protein Tyrosine Kinase/RTK / DDR1/DDR2 Receptor / DDR Inhibitor
CAS No.: 1644069-80-6
DDR Inhibitor is a potent discoidin domain receptor (DDR) inhibitor, with an IC50 of 3.3 nM for DDR2, and shows 53% inhibition on DDR1 at 1.5 nM.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT02516111 | Chronic Periodontitis | Phase 2 Phase 3 | Completed | - | - |
NCT02600520 | Chronic Periodontitis | Phase 2 Phase 3 | Completed | - | - |
NCT03404960 | Pancreatic Adenocarcinoma | Phase 1 Phase 2 | Recruiting | June 2021 | United States, Pennsylvania ... more >> University of Pennsylvania, Abramson Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Danielle Karlson 215-220-9704 danielle.Karlson@uphs.upenn.edu Principal Investigator: Kim Reiss Binder, MD Collapse << |
实验方案
技术信息
CAS号 | 1644069-80-6 | 储存条件 |
|
|
分子式 | C23H20FN5O2 | 运输 | 蓝冰 | |
分子量 | 417.44 | 别名 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT02516111 | Chronic Periodontitis | Phase 2 Phase 3 | Completed | - | - |
NCT02600520 | Chronic Periodontitis | Phase 2 Phase 3 | Completed | - | - |
NCT03404960 | Pancreatic Adenocarcinoma | Phase 1 Phase 2 | Recruiting | June 2021 | United States, Pennsylvania ... more >> University of Pennsylvania, Abramson Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Danielle Karlson 215-220-9704 danielle.Karlson@uphs.upenn.edu Principal Investigator: Kim Reiss Binder, MD Collapse << |
NCT03609216 | Infiltrating Bladder Urothelia... more >>l Carcinoma Stage II Bladder Urothelial Carcinoma Stage III Bladder Urothelial Carcinoma Collapse << | Phase 2 | Recruiting | February 2029 | - |
NCT03448718 | Metastatic Urothelial Cancer | Phase 2 | Recruiting | March 2023 | United States, Illinois ... more >> University of Chicago Medical Center Recruiting Chicago, Illinois, United States, 60637 Contact: Glenna Smith Conley 773-834-2143 gsmith6@bsd.uchicago.edu Principal Investigator: Peter O'Donnell, MD United States, New York Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10029-6542 Contact: Matthew Galsky 212-824-5452 matthew.galsky@mssm.edu United States, Utah Huntsman Cancer Institute University of Utah Recruiting Salt Lake City, Utah, United States, 84112-5550 Contact: Sumati Gupta, MD sumati.gupta@hci.utah.edu Principal Investigator: Sumati Gupta, MD Collapse << |
NCT03395197 | mCRPC | Phase 3 | Recruiting | November 2024 | United States, Alaska ... more >> Alaska Urological Institute dba Alaska Clinical Research Center Not yet recruiting Anchorage, Alaska, United States, 99503 United States, Arizona Urological Associates of Southern Arizona, PC Recruiting Tucson, Arizona, United States, 85715 Urological Associates of Southern Arizona, P.C. Recruiting Tucson, Arizona, United States, 85741 United States, California Marin Cancer Care, Inc. Not yet recruiting Greenbrae, California, United States, 94904 San Diego Clinical Trials Not yet recruiting San Diego, California, United States, 92120 United States, Colorado The Urology Center of Colorado Recruiting Denver, Colorado, United States, 80211 United States, Nebraska GU Research Network/Urology Cancer Center Recruiting Omaha, Nebraska, United States, 68130 United States, New Jersey New Jersey Urology, LLC Not yet recruiting Voorhees, New Jersey, United States, 08043 United States, New York Premier Medical Group of the Hudson Valley PC Not yet recruiting Poughkeepsie, New York, United States, 12601 Associated Medical Professionals of New York, PLLC Not yet recruiting Syracuse, New York, United States, 13210 United States, Ohio TriState urologic Services PSC Inc., dba The Urology Group Not yet recruiting Cincinnati, Ohio, United States, 45212 United States, South Carolina Carolina Urologic Research Center Recruiting Myrtle Beach, South Carolina, United States, 29572 United States, Tennessee Urology Associates P.C. Not yet recruiting Nashville, Tennessee, United States, 37209 United States, Utah University of Utah, Huntsman Cancer Hospital Recruiting Salt Lake City, Utah, United States, 84112 University of Utah, Huntsman Cancer Institute Recruiting Salt Lake City, Utah, United States, 84112 Collapse << |
NCT01491633 | Squamous Cell Lung Cancer | Phase 2 | Terminated(Safety issues/conce... more >>rns per DF/HCC PI) Collapse << | - | United States, Massachusetts ... more >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Collapse << |
NCT01491633 | - | - | Terminated(Safety issues/conce... more >>rns per DF/HCC PI) Collapse << | - | - |
NCT02067416 | Breast Cancer | Phase 2 | Terminated(Funding agent withd... more >>rew funding) Collapse << | - | United States, Texas ... more >> Houston Methodist Hospital Houston, Texas, United States, 77030 Collapse << |
NCT01514864 | Carcinoma, Non-small Cell Lung | Phase 2 | Terminated(Lack of efficacy an... more >>d slow accrual) Collapse << | - | United States, Florida ... more >> H. Lee Moffitt Cancer & Research Institute Tampa, Florida, United States, 33612 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Brazil Local Institution Barretos, Sao Paulo, Brazil, 14784 Local Institution S?o Paulo, Sao Paulo, Brazil, 05403 Canada, Ontario The Ottawa Hospital Cancer Centre Ottawa, Ontario, Canada, K1H 8L6 Germany Local Institution Frankfurt, Germany, 60488 Local Institution Heidelberg, Germany, 69120 Local Institution Heidelberg, Germany, 69126 Local Institution Koeln, Germany, 50924 Local Institution Koeln, Germany, 50931 Poland Local Institution Gdansk, Poland, 80-219 Local Institution Lodz, Poland, 93-509 Local Institution Warsaw, Poland, 02-781 Taiwan Local Institution Taipei, Taiwan, 112 United Kingdom Local Institution Cambridge, Cambridgeshire, United Kingdom, CB2 2QQ Local Institution London, Greater London, United Kingdom, SW3 6JJ Local Institution Manchester, Greater Manchester, United Kingdom, M20 4BX Local Institution Edinburgh, Midlothian, United Kingdom, EH4 2XU Local Institution Sutton, Surrey, United Kingdom, SM2 5PT Local Institution Gwent, United Kingdom, NP20 2UB Collapse << |
NCT01625286 | Advanced or Metastatic Breast ... more >>Cancer ER+ve Advanced or Metastatic Breast Cancer Collapse << | Phase 1 Phase 2 | Active, not recruiting | March 29, 2019 | - |
NCT02465060 | Advanced Malignant Solid Neopl... more >>asm Bladder Carcinoma Breast Carcinoma Cervical Carcinoma Colon Carcinoma Colorectal Carcinoma Endometrial Carcinoma Esophageal Carcinoma Gastric Carcinoma Glioma Head and Neck Carcinoma Kidney Carcinoma Liver and Intrahepatic Bile Duct Carcinoma Lung Carcinoma Lymphoma Malignant Uterine Neoplasm Melanoma Ovarian Carcinoma Pancreatic Carcinoma Plasma Cell Myeloma Prostate Carcinoma Rectal Carcinoma Recurrent Bladder Carcinoma Recurrent Breast Carcinoma Recurrent Cervical Carcinoma Recurrent Colon Carcinoma Recurrent Colorectal Carcinoma Recurrent Esophageal Carcinoma Recurrent Gastric Carcinoma Recurrent Glioma Recurrent Head and Neck Carcinoma Recurrent Liver Carcinoma Recurrent Lung Carcinoma Recurrent Lymphoma Recurrent Malignant Solid Neoplasm Recurrent Melanoma Recurrent Ovarian Carcinoma Recurrent Pancreatic Carcinoma Recurrent Plasma Cell Myeloma Recurrent Prostate Carcinoma Recurrent Rectal Carcinoma Recurrent Skin Carcinoma Recurrent Thyroid Gland Carcinoma Recurrent Uterine Corpus Carcinoma Refractory Lymphoma Refractory Malignant Solid Neoplasm Refractory Plasma Cell Myeloma Skin Carcinoma Thyroid Gland Carcinoma Uterine Corpus Cancer Collapse << | Phase 2 | Recruiting | - | - |
NCT03037606 | Gastroesophageal Reflux Diseas... more >>e Collapse << | Phase 4 | Completed | - | Turkey ... more >> Ege University Facult of Medicine Gastroenterology Department Izmir, Turkey, 35100 Collapse << |
NCT03330405 | Avelumab in Combination With T... more >>alazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors Collapse << | Phase 2 | Recruiting | March 28, 2020 | - |
NCT03022409 | Head and Neck Squamous Cell Ca... more >>rcinoma Collapse << | Phase 1 | Recruiting | September 3, 2019 | United States, Pennsylvania ... more >> Research Site Recruiting Pittsburgh, Pennsylvania, United States, 15240 Research Site Not yet recruiting Pittsburgh, Pennsylvania, United States, 15240 France Research Site Not yet recruiting Toulouse cedex 9, France, 31052 Research Site Not yet recruiting Villejuif, France, 94805 Taiwan Research Site Not yet recruiting Taipei, Taiwan, 100 United Kingdom Research Site Not yet recruiting Birmingham, United Kingdom, B15 2TT Research Site Not yet recruiting Manchester, United Kingdom, M20 4BX Collapse << |
NCT03740893 | Breast Neoplasm | Phase 2 | Not yet recruiting | August 2023 | United Kingdom ... more >> Royal Bournemouth Hospital Not yet recruiting Bournemouth, Dorset, United Kingdom, BH7 7DW Bristol Haematology and Oncology Centre Not yet recruiting Bristol, England, United Kingdom, BS2 8ED King's College Hospital London, England, United Kingdom, SE5 9RS Christie Hospital NHS Trust Not yet recruiting Manchester, England, United Kingdom, M20 4BX Belfast City Hospital Not yet recruiting Belfast, Northern Ireland, United Kingdom, BT9 7AB Velindre Cancer Center at Velinde Hospital Not yet recruiting Cardiff, Wales, United Kingdom, CF14 2TL Queen Elizabeth Hospital, University Hospitals Birmingham NHS Trust Not yet recruiting Birmingham, United Kingdom Guy's and St Thomas' Hospital NHS Foundation Trust Not yet recruiting London, United Kingdom, SE1 9RT Weston Park Hospital Not yet recruiting Sheffield, United Kingdom Collapse << |
NCT01514864 | - | - | Terminated(Lack of efficacy an... more >>d slow accrual) Collapse << | - | - |
NCT03207347 | Mesothelioma ... more >>Uveal Melanoma Renal Cell Carcinoma Cholangiocarcinoma Collapse << | Phase 2 | Recruiting | December 2022 | United States, Florida ... more >> University of Florida Recruiting Gainesville, Florida, United States, 32610 Principal Investigator: Thomas George, MD, FACP Collapse << |
NCT02219711 | Advanced Cancer | Phase 1 | Recruiting | March 2019 | - |
NCT03678883 | Cancer Lympho... more >>ma Pancreatic Cancer Glioblastoma Multiforme Sarcoma Breast Cancer Bladder Cancer Renal Cancer Ovarian Cancer Refractory Cancer Refractory Neoplasm Refractory Non-Hodgkin Lymphoma Refractory Brain Tumor Pancreatic Adenocarcinoma Resistant Cancer Neoplasm Metastasis Neoplasm of Bone Neoplasm, Breast Neoplasm of Lung Neoplasms,Colorectal Neoplasms Pancreatic Malignant Glioma Malignancies Malignancies Multiple Bone Metastases Bone Neoplasm Bone Cancer Pancreas Cancer Pancreatic Neoplasms Breast Neoplasms Collapse << | Phase 1 Phase 2 | Recruiting | November 2022 | United States, Rhode Island ... more >> Rhode Island Hospital Recruiting Providence, Rhode Island, United States, 02903 Contact: Benedito Carneiro, MD Benedito.Carneiro@Lifespan.org Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网